The integrin-linked kinase is required for chemokine-triggered high-affinity conformation of the neutrophil β2-integrin LFA-1.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
05 11 2020
Historique:
received: 15 01 2020
accepted: 11 07 2020
pubmed: 31 7 2020
medline: 23 3 2021
entrez: 31 7 2020
Statut: ppublish

Résumé

Neutrophil adhesion and extravasation into tissue at sites of injury or infection depend on binding of the integrin lymphocyte function-associated antigen 1 (LFA-1) to ICAM-1 expressed on activated endothelial cells. The activation-dependent conformational change of LFA-1 to the high-affinity conformation (H+) requires kindlin-3 binding to the β2-integrin cytoplasmic domain. Here we show that genetic deletion of the known kindlin interactor integrin-linked kinase (ILK) impaired neutrophil adhesion and extravasation in the cremaster muscle and in a clinically relevant model of renal ischemia reperfusion injury. Using in vitro microfluidic adhesion chambers and conformation-specific antibodies, we show that knockdown of ILK in HL-60 cells reduced the conformational change of β2-integrins to the H+ conformation. Mechanistically, we found that ILK was required for protein kinase C (PKC) membrane targeting and chemokine-induced upregulation of its kinase activity. Moreover, PKC-α deficiency also resulted in impaired leukocyte adhesion in bone marrow chimeric mice. Mass spectrometric and western blot analyses revealed stimulation- and ILK-dependent phosphorylation of kindlin-3 upon activation. In summary, our data indicate an important role of ILK in kindlin-3-dependent conformational activation of LFA-1.

Identifiants

pubmed: 32730588
pii: S0006-4971(21)00496-1
doi: 10.1182/blood.2020004948
doi:

Substances chimiques

CD18 Antigens 0
Chemokines 0
FERMT3 protein, human 0
Lymphocyte Function-Associated Antigen-1 0
Membrane Proteins 0
Neoplasm Proteins 0
integrin-linked kinase EC 2.7.1.-
Protein Serine-Threonine Kinases EC 2.7.11.1
Protein Kinase C EC 2.7.11.13

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2200-2205

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 by The American Society of Hematology.

Auteurs

Andreas Margraf (A)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Giulia Germena (G)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Hannes C A Drexler (HCA)

Max Planck Institute for Molecular Biomedicine, Muenster, Germany.

Jan Rossaint (J)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Nadine Ludwig (N)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Barbara Prystaj (B)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Sina Mersmann (S)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Katharina Thomas (K)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Helena Block (H)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Wiebke Gottschlich (W)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Chang Liu (C)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.
Department of Critical Care Medicine, First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Peter W Krenn (PW)

Department of Molecular Medicine, Max Planck Institute of Biochemistry, Martinsried, Germany.

Hermann Haller (H)

Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany.

Barbara Heitplatz (B)

Gerhard Domagk Institute of Pathology, University Hospital Muenster, Muenster, Germany; and.

Marika Meyer Zu Brickwedde (M)

Max Planck Institute for Molecular Biomedicine, Muenster, Germany.

Markus Moser (M)

Center for Translational Cancer Research, TUM School of Medicine, Technische Universität München, Munich, Germany.

Dietmar Vestweber (D)

Max Planck Institute for Molecular Biomedicine, Muenster, Germany.

Alexander Zarbock (A)

Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Muenster, Muenster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH